Cargando…
Modeling the future of HIV in Turkey: Cost-effectiveness analysis of improving testing and diagnosis
AIMS: This study aimed to determine HIV incidence and prevalence in Turkey and to estimate the cost-effectiveness of improving testing and diagnosis in the next 20 years. BACKGROUND: HIV incidence in Turkey has been rapidly increasing in the last decade with a particularly high rate of infection for...
Autores principales: | Yaylali, Emine, Erdogan, Zikriye Melisa, Calisir, Fethi, Gokengin, Deniz, Korten, Volkan, Tabak, Fehmi, Tasova, Yesim, Unal, Serhat, Ozelgun, Berna, Ozcagli, Tahsin Gokcem, Sahin, Toros |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10313051/ https://www.ncbi.nlm.nih.gov/pubmed/37390076 http://dx.doi.org/10.1371/journal.pone.0286254 |
Ejemplares similares
-
Cost-Effectiveness Analysis of Remdesivir Treatment in COVID-19 Patients Requiring Low-Flow Oxygen Therapy: Payer Perspective in Turkey
por: Oksuz, Ergun, et al.
Publicado: (2021) -
Comparison of Risk Category Predictions of Framingham Risk Score (FRS), Atherosclerotic Cardiovascular Disease Risk Score (ASCVD), Systematic Coronary Risk Evaluation (SCORE) and Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) in HIV Infected Patients
por: Korten, Volkan, et al.
Publicado: (2017) -
SARS-CoV-2 epidemiology and control, different scenarios for Turkey
por: PETERSEN, Eskild, et al.
Publicado: (2020) -
Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey
por: Tanriover, Mine Durusu, et al.
Publicado: (2021) -
Rickettsia sibirica mongolitimonae Infection, Turkey, 2016
por: Kuscu, Ferit, et al.
Publicado: (2017)